Proof-of-concept studies in LQTS models, particularly for KCNH2 (LQT2), have demonstrated that antisense oligonucleotides can modulate splicing and increase functional channel expression, drawing on lessons from cystic fibrosis and other channelopathies. This evidence concerns the gene KCNH2 and familial long QT syndrome.